Reuters logo
REFILE-TABLE-Astellas -9-MTH group results (IFRS)
February 2, 2015 / 3:31 AM / 3 years ago

REFILE-TABLE-Astellas -9-MTH group results (IFRS)

(Operating forecast is core operating forecast, EPS forecast is core EPS forecast.)
Feb 2 (Reuters)- 
              Astellas Pharma Inc. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2014        Dec 31, 2013     Mar 31, 2015 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              952.77              868.26          1.21 trln  
                   (+9.7 pct)                           (+6.1 pct)  
  Operating          161.68              112.88           210.00    
                   (+43.2 pct)                          (+12.7 pct) 
  Pretax             161.62              115.44                     
                   (+40.0 pct)                                      
  Net                114.74               83.46                     
                   (+37.5 pct)                                      
  EPS Basic         51.87 yen           37.06 yen        69.65 yen  
  EPS Diluted       51.79 yen           37.01 yen                   
  Ann Div                              135.00 yen        30.00 yen  
  -Q2 Div           14.00 yen           65.00 yen                   
  -Q4 Div                               70.00 yen        16.00 yen  
  NOTE - Astellas Pharma Inc. is a major pharmaceutical maker, which was formed from the merger
of Yamanouchi Pharmaceutical Co. Ltd. and Fujisawa Pharmaceutical Co. Ltd. on April 1, 2005. 
 . 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  For latest earnings estimates made by Toyo Keizai, please double click on.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below